Cargando…
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy
A 43‐year‐old man with a 23‐year history of type II diabetes presented with uncontrolled hyperglycemia with frequent episodes of ketoacidosis. He was diagnosed with exogenous insulin antibody syndrome, and received high‐dose methylprednisolone to treat insulin resistance. Ketoacidosis relapsed 2 yea...
Autores principales: | Zhuang, Yuan, Wei, Xudong, Yu, Yang, Wang, Deqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453898/ https://www.ncbi.nlm.nih.gov/pubmed/34013991 http://dx.doi.org/10.1002/jca.21905 |
Ejemplares similares
-
A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange
por: Meguri, Yusuke, et al.
Publicado: (2018) -
Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy
por: Jerkins, Terri, et al.
Publicado: (2021) -
Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients
por: Hu, Xiaolei, et al.
Publicado: (2017) -
Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes
por: Han, Chen-Yu, et al.
Publicado: (2023) -
Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
por: Su, Chih-Ting, et al.
Publicado: (2016)